Opyl
Click to visit website
About
Opyl is an innovative Australian digital health company that harnesses artificial intelligence to enhance clinical trial design and predict outcomes. Aimed at empowering clinical researchers, biopharmaceutical firms, and medical investors, the platform offers a robust tool known as TrialKey, which utilizes AI and GPT-4 to analyze extensive data from historical clinical trials. This pioneering approach achieves a remarkable accuracy rate of over 90% in predicting trial success while also providing insights and recommendations to overcome trial challenges, ultimately accelerating medical research efforts.
Platform
Task
Features
• ai-powered clinical trial prediction
• clinical trial design optimization
• high accuracy rate of +90%
• utilizes real-world trial data
• tailored insights and recommendations
Average Rating: 0.0
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
User Ratings
No ratings available.
Sign In to Rate this Tool
Alternatives
Elix
Patient centric platform for clinical trials enhancing patient engagement and compliance through AI.
View Details
Neuroute
Neuroute uses AI to enhance clinical trial execution, site selection, and patient enrollment modeling.
View Details
Featured Tools
Dezyn
Interactive architectural diagram tool with AI-powered features for flowcharts and cloud architectures.
View Details
Choice AI
Personalized OTT entertainment platform using AI for tailored viewing experiences.
View Details